Allianz’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Sell
5,303
-6,036
-53% -$1.35M 0.01% 280
2025
Q4
$1.94M Sell
11,339
-1,433
-11% -$223K 0.03% 209
2025
Q3
$1.71M Buy
12,772
+9,312
+269% +$986K 0.04% 198
2025
Q2
$337K Sell
3,460
-16,710
-83% -$1.33M 0.01% 270
2025
Q1
$1.47M Buy
20,170
+1,202
+6% +$94.7K 0.04% 206
2024
Q4
$1.37M Buy
+18,968
New +$1.44M 0.04% 204

Other funds holding LRCX

Allianz's LRCX Position: Q1 2026 in Review

Allianz reduced its Lam Research (LRCX) stake by 53% in Q1 2026, selling an estimated $1.35M and leaving 5,303 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #280.

Allianz first reported a position in LRCX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.94M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Allianz held 5,303 shares of Lam Research worth $1.13M as of Q1 2026.
  • Allianz sold 6,036 Lam Research shares in Q1 2026, an estimated $1.35M.
  • Lam Research made up 0.01% of Allianz's portfolio in Q1 2026, its #280 holding.
  • Allianz first reported a position in Lam Research in Q4 2024 and has held it in 6 quarters since.
  • Allianz's Lam Research position peaked at $1.94M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Allianz's 13F filing for Q1 2026, filed 11 May 2026.